Early results from the Micra investigational trial (IDE) and Micra post-approval registry (PAR) demonstrated excellent safety and efficacy performance; however, intermediate-term results across a large patient population in the real-world setting have not been evaluated.
We report updated performance of the Micra transcatheter pacemaker from a worldwide PAR and compare with the IDE and transvenous historical control results.
El-Chami MF, Al-Samadi F, Clementy N, Garweg C, Martinez-Sande JL, Piccini JP, Iacopino S, Lloyd M, Viñolas Prat X, Jacobsen MD, Ritter P, Johansen JB, Tondo C, Liu F, Fagan DH, Eakley AK, Roberts PR. Updated Performance of the Micra Transcatheter Pacemaker in the Real-World Setting: A Comparison to the Investigational Study and a Transvenous Historical Control. Heart Rhythm 2018 Aug 10. pii: S1547-5271(18)30792-6. doi: 10.1016/j.hrthm.2018.08.005. [Epub ahead of print]